Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994
Antibody-Mediated Encephalitis
NEJM 378:840-851, Dalmau, J.,et al, 2018
Investigations in GABA? Receptor Antibody-Associated Encephalitis
Neurol 88:1012-1020,1010, Spatola, M.,et al, 2017
Overlooked non-motor Symptoms in Myasthenia Gravis
JNNP 84:989-994, Suzuki, S.,et al, 2013
Clinicopathologic Conference, Inflammatory Myopathy and Myasthenia Gravis Assoc. with Thymoma
NEJM 369:764-773, Case 26-2013, 2013
Development of Generalized Disease at 2 Years in Patients with Ocular Myasthenia Gravis
Arch Neurol 60:243-248, Kupersmith,M.J.,et al, 2003
Paraneoplastic Syndromes Involving the Nervous System
NEJM 349:1543-1554, Darnell,R.B. &Posner,J.B., 2003
Thymoma in Patients with MG
Neurol 59:1844-1850, Evoli,A.,et al, 2002
The Long-Term Clinical Outcome of Myasthenia Gravis in Patients with Thymoma
Neurol 51:1198-1200, Bril,V.,et al, 1998
Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994
The Natural Course of Myasthenia Gravis:A Long Term Follow Up Study
JNNP 52:1121-1127, Oosterhuis,H.J.G., 1989
Cause of Weakness in Myasthenia Gravis
NEJM 294:722, Grob,D., 1976